Even though the deletion of adiponectin exclusively in HSCs has no impact on the circulating adiponectin pool, it is sufficient to dramatically accelerate liver fibrosis progression in different mouse models of liver injury. Here, ADIPOQ is linked to Hepatic fibrosis.